2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons

Circulation

Volumn 130, Issue 19, 2014, Pages 1749-1767

  Fihn, Stephan D ^a   Blankenship, James C ^a   Alexander, Karen P ^a   Bittl, John A ^a   Byrne, John G ^b   Fletcher, Barbara J ^c   Fonarow, Gregg C ^d   Lange, Richard A ^a   Levine, Glenn N ^a   Maddox, Thomas M ^a   Naidu, Srihari S ^e   Ohman, E Magnus ^f   Smith, Peter K ^g   Anderson, Jeffrey L ^h   Halperin, Jonathan L ^h   Albert, Nancy M ^h   Bozkurt, Biykem ^h   Brindis, Ralph G ^h   Curtis, Lesley H ^h   Demets, David ^h   Guyton, Robert A ^h   Hochman, Judith S ^h   Kovacs, Richard J ^h   Pressler, Susan J ^h   Sellke, Frank W ^h   Shen, Win Kuang ^h   more..

^a ACC AHA Representative   (United States)

^b The American Association for Thoracic Surgery   (United States)

^c Preventive Cardiovascular Nurses Association Representative   (United States)

^d ACC AHA Task Force on Performance Measures Liaison   (United States)

^e Society for Cardiovascular Angiography and Interventions Representative   (United States)

^f ACC AHA Task Force on Practice Guidelines Liaison   (United States)

^g Society of Thoracic Representative   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

ALTERNATIVE MEDICINE; ANGINA PECTORIS; CHELATION THERAPY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; COUNTERPULSATION; DIABETES MELLITUS; DRUG ELUTING CORONARY STENT; ENHANCED EXTERNAL COUNTERPULSATION; HEART DEATH; HEART INFARCTION; HUMAN; INVASIVE PROCEDURE; ISCHEMIC HEART DISEASE; LEFT CORONARY ARTERY; META ANALYSIS (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STABLE ISCHEMIC HEART DISEASE; ANGINA, STABLE; ANGIOCARDIOGRAPHY; CARDIOLOGY; HEART CATHETERIZATION; MEDICAL SOCIETY; MYOCARDIAL ISCHEMIA; STANDARDS; UNITED STATES;

AMERICAN HEART ASSOCIATION; ANGINA, STABLE; CARDIAC CATHETERIZATION; CARDIOLOGY; CORONARY ANGIOGRAPHY; HUMANS; MYOCARDIAL ISCHEMIA; PERCUTANEOUS CORONARY INTERVENTION; UNITED STATES;

EID: 84918592681     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000095     Document Type: Review

References (92)

1. American College of Cardiology/American Heart Association: Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines. Available at: http://assets.cardiosource.com/Methodology-Manual-for-ACC-AHA-Writing-Committees.pdf. J Am Coll Cardiol. Accessed April 29, 2014.
2. Institute of Medicine (U.S.). Finding What Works in Health Care: Standards for Systematic Reviews. Washington, D.C.: National Academies Press, 2011.
3. Institute of Medicine (U.S.). Committee on Standards for Developing Trustworthy Clinical Practice Guidelines: Clinical Practice Guidelines We Can Trust. Washington, D.C.: National Academies Press, 2011.
4. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:354-471.
5. de Bruyne, B, Pijls NHJ, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991-1001.
6. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:3097-137.
7. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation. 1979;59:421-30.
8. Mark DB, Hlatky MA, Harrell FE Jr., et al. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med. 1987;106:793-800.
9. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:574-651.
10. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:652-735.
11. Patel MR, Bailey SR, Bonow RO, et al. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;59:1995-2027.
12. Bittl JA, He Y, Jacobs AK, et al. Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease. Circulation. 2013;127:2177-85.
13. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:240-327.
14. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Circulation. 2006;114:1088-132.
15. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery [published online ahead of print August 1, 2014]. Circulation. doi:10.1161/CIR.0000000000000106.
16. Lentine KL, Costa SP, Weir MR, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2012;126:617-63.
17. Raval Z, Harinstein ME, Skaro AI, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol. 2011;58:223-31.
18. Mark DB, Berman DS, Budoff MJ, et al. ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation. 2010;121:2509-43.
19. Taylor AJ, Cerqueira M, Hodgson JM, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2010;122:525-55.
20. Leape LL, Park RE, Bashore TM, et al. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. Am Heart J. 2000;139:106-13.
21. Fleming RM, Kirkeeide RL, Smalling RW, et al. Patterns in visual interpretation of coronary arteriograms as detected by quantitative coronary arteriography. J Am Coll Cardiol. 1991;18:945-51.
22. Nallamothu BK, Spertus JA, Lansky AJ, et al. Comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: The Assessing Angiography (A2) project. Circulation. 2013;127:1793-800.
23. Anderson RD, Pepine CJ. Coronary angiography: is it time to reassess? Circulation. 2013;127:1760-2.
24. Kern MJ, Samady H. Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol. 2010;55:173-85.
25. Bech GJ, de Bruyne, B, Pijls NH, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: A randomized trial. Circulation. 2001;103:2928-34.
26. Tonino PAL, de Bruyne B., Pijls NHJ, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213-24.
27. Pijls NHJ, Fearon WF, Tonino PAL, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010;56:177-84.
28. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation. 1999;99:2345-57.
29. Dehmer GJ, Weaver D, Roe MT, et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: A report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol. 2012;60:2017-31.
30. Batyraliev T, Ayalp MR, Sercelik A, et al. Complications of cardiac catheterization: A single-center study. Angiology. 2005;56:75-80.
31. Chandrasekar B, Doucet S, Bilodeau L, et al. Complications of cardiac catheterization in the current era: A single-center experience. Catheter Cardiovasc Interv. 2001;52:289-95.
32. West R, Ellis G, Brooks N, et al. Complications of diagnostic cardiac catheterisation: Results from a confidential inquiry into cardiac catheter complications. Heart. 2006;92:810-4.
33. Levine GN, Kern MJ, Berger PB, et al. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med. 2003;139:123-36.
34. Ko DT, Wang Y, Alter DA, et al. Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction. J Am Coll Cardiol. 2008;51:716-23.
35. Douglas PS, Patel MR, Bailey SR, et al. Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography. J Am Coll Cardiol. 2011;58:801-9.
36. Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362:886-95.
37. Bradley SM, Maddox TM, Stanislawski MA, et al. Normal coronary rates for elective angiography in the Veterans Affairs Healthcare System: insights from the VA CART Program (Veterans Affairs Clinical Assessment Reporting and Tracking). J Am Coll Cardiol. 2014;63:417-26.
38. Guldager B, Jelnes R, Jørgensen SJ, et al. EDTA treatment of intermittent claudication- A double-blind, placebo-controlled study. J Intern Med. 1992;231:261-7.
39. van Rij, AM, Solomon C, Packer SG, et al. Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial. Circulation. 1994;90:1194-9.
40. Sloth-Nielsen J, Guldager B, Mouritzen C, et al. Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis. Am J Surg. 1991;162:122-5.
41. Knudtson ML, Wyse DG, Galbraith PD, et al. Chelation therapy for ischemic heart disease: A randomized controlled trial. JAMA. 2002;287:481-6.
42. Lamas GA, Goertz C, Boineau R, et al. Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: The TACT randomized trial. JAMA. 2013;309:1241-50.
43. Tellez-Plaza M, Guallar E, Howard BV, et al. Cadmium exposure and incident cardiovascular disease. Epidemiology. 2013;24:421-9.
44. Xun P, Liu K, Morris S, et al. Association of toenail cadmium levels with measures of sub-clinical atherosclerosis: The Coronary Artery Risk Development in Young Adults (CARDIA) Trace Element Study. In: Abstracts From the Epidemiology and Prevention/Physical Activity, Nutrition and Metabolism 2012 Scientific Sessions (abstr P301). Circulation 2012;125 Suppl: 301.
45. Centers for Disease Control and Prevention (CDC). Deaths associated with hypocalcemia from chelation therapy-Texas, Pennsylvania, and Oregon, 2003-2005. MMWR Morb Mortal Wkly Rep. 2006;55:204-7.
46. Howland MA. Edetate calcium disodium (CaNa2EDTA). In Nelson L, Goldfrank LR, editors. Goldfrank's Toxicologic Emergencies. New York: McGraw-Hill Medical, 2011:1290-3.
47. Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): Effect of EECP on exerciseinduced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999;33:1833-40.
48. Akhtar M, Wu GF, Du ZM, et al. Effect of external counterpulsation on plasma nitric oxide and endothelin-1 levels. Am J Cardiol. 2006;98:28-30.
49. Shechter M, Matetzky S, Feinberg MS, et al. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol. 2003;42:2090-5.
50. Urano H, Ikeda H, Ueno T, et al. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001;37:93-9.
51. Braith RW, Conti CR, Nichols WW, et al. Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: A randomized sham-controlled study. Circulation. 2010;122:1612-20.
52. Shah SA, Shapiro RJ, Mehta R, et al. Impact of enhanced external counterpulsation on Canadian Cardiovascular Society angina class in patients with chronic stable angina: A meta- Analysis. Pharmacotherapy. 2010;30:639-45.
53. Stys TP, Lawson WE, Hui JCK, et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol. 2002;89:822-4.
54. Barsness G, Feldman AM, Holmes DRJ, et al. The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin Cardiol. 2001;24:435-42.
55. Wu E, Mårtensson J, Broström A. Enhanced external counterpulsation in patients with refractory angina pectoris: A pilot study with six months follow-up regarding physical capacity and health-related quality of life. Eur J Cardiovasc Nurs. 2013;12:437-45.
56. McKenna C, McDaid C, Suekarran S, et al. Enhanced external counterpulsation for the treatment of stable angina and heart failure: A systematic review and economic analysis. Health Technol Assess. 2009;13:iii-iv, ix-xi, 1-90.
57. Amin F, Al-Hajeri A., Civelek B, et al. Enhanced external counterpulsation for chronic angina pectoris. Cochrane Database Syst Rev. 2010;CD007219.
58. Sorajja P, Chareonthaitawee P, Rajagopalan N, et al. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting. Circulation. 2005;112:1311-6.
59. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997;96:1761-9.
60. Banning AP, Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55:1067-75.
61. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta- Analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- To eight-year outcomes. J Am Coll Cardiol. 2003;41:1293-304.
62. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082-9.
63. Malenka DJ, Leavitt BJ, Hearne MJ, et al. Comparing long- Term survival of patients with multivessel coronary disease after CABG or PCI: Analysis of BARI-like patients in northern New England. Circulation. 2005;112:1371-6.
64. Niles NW, McGrath PD, Malenka D, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: Results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol. 2001;37:1008-15.
65. Weintraub WS, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol. 1998;31:10-9.
66. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary- Artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-72.
67. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375-84.
68. Hannan EL, Racz MJ, Walford G, et al. Long- Term outcomes of coronary- Artery bypass grafting versus stent implantation. N Engl J Med. 2005;352:2174-83.
69. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronaryartery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358:331-41.
70. Briguori C, Condorelli G, Airoldi F, et al. Comparison of coronary drugeluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol. 2007;99:779-84.
71. Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drugeluting stents for patients with multivessel coronary artery disease. Circulation. 2007;116:1200-6.
72. Lee MS, Jamal F, Kedia G, et al. Comparison of bypass surgery with drugeluting stents for diabetic patients with multivessel disease. Int J Cardiol. 2007;123:34-42.
73. Park DW, Yun SC, Lee SW, et al. Long- Term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation. 2008;117:2079-86.
74. Tarantini G, Ramondo A, Napodano M, et al. PCI versus CABG for multivessel coronary disease in diabetics. Catheter Cardiovasc Interv. 2009;73:50-8.
75. Varani E, Balducelli M, Vecchi G, et al. Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical revascularization in patients with multivessel coronary artery disease: one-year clinical results and total treatment costs. J Invasive Cardiol. 2007;19:469-75.
76. Yang JH, Gwon HC, Cho SJ, et al. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease. Ann Thorac Surg. 2008;85:65-70.
77. Yang ZK, Shen WF, Zhang RY, et al. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. J Interv Cardiol. 2007;20:10-6.
78. Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012;366:1467-76.
79. Benedetto U, Melina G, Angeloni E, et al. Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A metaanalysis on 24, 268 patients. Eur J Cardiothorac Surg. 2009;36:611-5.
80. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121:2645-53.
81. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011;32:2125-34.
82. Kappetein AP, Head SJ, Morice MC, et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg. 2013;43:1006-13.
83. Ragosta M, Dee S, Sarembock IJ, et al. Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main coronary artery disease. Catheter Cardiovasc Interv. 2006;68:357-62.
84. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with threevessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381:629-38.
85. Buszman PE, Kiesz SR, Bochenek A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol. 2008;51:538-45.
86. Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. 2011;364:1718-27.
87. Naik H, White AJ, Chakravarty T, et al. A meta- Analysis of 3, 773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. JACC Cardiovasc Interv. 2009;2:739-47.
88. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012;126:875-910.
89. Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:663-828.
90. Daemen J, Boersma E, Flather M, et al. Long- Term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: A meta- Analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation. 2008;118:1146-54.
91. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: A collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373:1190-7.
92. Verma S, Farkouh ME, Yanagawa B. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: A meta- Analysis of randomised controlled trials. The Lancet Diabetes & Endocrinology. 2013;1:317-28.